The FEATURE study provides the first prospective validation of FDG-PET/CT and PERCIST response criteria in patients presenting with bone-only or bone-dominant metastatic breast cancer, opening the ...

Yet another electric vehicle charging company is targeting Southeast Michigan for operations. German EV charging company EcoG GMBH plans to invest $14.4 million and create a North American ...

A legacy of mentorship continues and expands: over three decades of Young Investigators of the Year; the Paul Carbone, MD Fellowship turns 20; and the Group honors its second Remarkable Mentor to ...

Oncology physicians' knowledge, attitudes, and practices regarding fertility preservation. Background: The ECOG PS scale is a widely used measure of functional status in oncology and is a good ...

New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...

Dunamis Charge to Add EcoG's Technology to its First-Generation DC Fast Chargers and Level 2 EV Residential and Commercial Chargers EcoG is seeking to expand rapidly in the United States after ...

It is essential for electric vehicles to be able to share stored power back to the grid so that they can provide needed stability during times of peak demand, but in the absence of a common standard ...

Results of a randomized phase II study of mitoxantrone versus mitoxantrone with cetuximab in metastatic castrate-resistant prostate cancer (CRPC) previously treated with docetaxel-based chemotherapy.

The research teams developed multimodal models to more precisely stratify recurrence risk in early-stage breast cancer. The models integrate histopathologic imaging, clinical, and molecular data ...